Developer docs
API playgroundTry for free, no card

Search company profiles

Medistrava

Full company profile

uuid000b788

Namestring
Medistrava
Legal namestring
MEDiSTRAVA
Websiteurl
medistrava.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Medistrava is an integrated medical solutions partner serving biotech and biopharma companies, operating as a specialty unit within Inizio Medical — itself part of the broader Inizio group comprising more than 11,500 experts across 50 countries. Founded in 2019 and headquartered in London, the company employs 150+ specialists (firmographics report a 251–500 employee range) and delivers services across seven practice areas: medical strategy and excellence, patient engagement, clinical trials optimization, medical analytics and innovation, value and evidence, and corporate and investor communications. The firm serves clients across the drug development lifecycle, from start-up through commercialization, with named customers spanning emerging biotech (Amber Therapeutics, Enara Bio, Quell Therapeutics, Nouscom, Avillion) through to large pharmaceutical companies (Boehringer Ingelheim, AstraZeneca). Disclosed cumulative track record includes IPO mandates on nine markets raising more than $3.5Bn, M&A transactions with total value of approximately $18Bn, partnering transactions exceeding $23Bn, VC financings above $5Bn, and private financings of approximately $2Bn over a 20+ year period.

Short descriptiontext

Medistrava is an Inizio Medical-owned, London-based professional services consultancy providing biotech and pharma companies with integrated medical affairs, clinical trials optimization, patient engagement, value and evidence, and corporate and investor communications services across seven practice areas.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical affairs consulting, clinical trial optimization, biotech communications, patient engagement services, pharmaceutical consulting
Industry2 codes
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
SECONDARYMPAAAAAJ
Healthcare/Pharma Creative Agencies
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)
NAICS code3 codes
  • Marketing Consulting Services541613
  • Other Scientific and Technical Consulting Services54169
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Consulting Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Professional Services - Medical Strategy and Excellence
TypeProfessional Services
Description

Consulting and strategic services spanning medical affairs transformation, evidence generation strategy, and market access support for biotech and pharma companies.

medistrava.com
2Clinical Trials Optimization Services
TypeProfessional Services
Description

End-to-end clinical trial consulting and advisory services covering recruitment planning, quality and risk management, trial diversity, and study start-up.

medistrava.com
3Patient Engagement Services
TypeProfessional Services
Description

Patient engagement strategic consultancy, insights gathering, and education/activation services across the drug development lifecycle.

medistrava.com
4Medical Analytics and Innovation
TypeProfessional Services
Description

Advanced analytics, digital innovation consulting, and AI-powered solutions for medical affairs and commercial teams.

medistrava.com
5Corporate and Investor Communications
TypeProfessional Services
Description

Strategic corporate and financial communications services including IPOs, secondary financings, M&A transactions, partnering transactions, and VC financings.

medistrava.com
6Value and Evidence Services
TypeProfessional Services
Description

Pricing and market access strategy, value communications, evidence generation, HEOR and RWE technical expertise along the commercialization pathway.

medistrava.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MEDiSTRAVA is an integrated medical solutions partner that delivers specialized consulting services to biotech and biopharma companies across the drug development lifecycle. Its core offering spans seven practice areas: Medical Strategy and Excellence, Patient Engagement, Clinical Trials Optimization, Medical Analytics and Innovation (including AI and augmented intelligence), Value and Evidence, and Corporate and Investor Communications. Two flagship technology platforms, iON AI and SITE iMPACT, augment these professional services with AI-powered analytics, content generation, and clinical trial recruitment optimization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Advisers to over 100 companies over 20+ year period
+4 more records
Product overview1 text field

MEDiSTRAVA is an integrated medical solutions partner offering a unified platform of specialized services for biotech and biopharma companies. The core offering is organized around seven practice areas: Medical strategy and excellence, Patient engagement (encompassing strategic consultancy, insights and co-creation, education and activation, and Inclusion and Impact), Clinical trials optimization (featuring the flagship SITE iMPACT solution with its three integrated sub-components: SITE iNSIGHTS, SITE eNGAGE, and SITE iNSPIRE), Medical analytics and innovation (including dedicated AI and augmented intelligence services), Value and evidence (with HEOR capabilities), and Corporate and investor communications. The company also offers iON AI as an AI-powered intelligence platform. All services are delivered by over 150 specialists and can be combined into bespoke cross-functional teams to provide scalable solutions from startup through commercialization.

Product and service8 records
1SITE iMPACT
CategoryClinical Trial Optimization
Description

Flagship clinical trial recruitment strategy combining data-driven site intelligence, real-time trial insights, mock trials, and proactive site engagement to help sponsors design recruitable studies and reduce rescue scenarios. Built on three integrated sub-components: SITE iNSIGHTS (analytics and data mapping), SITE eNGAGE (comprehensive site engagement strategy), and SITE iNSPIRE (patient and site-facing marketing and education materials).

2iON AI
CategoryMedical Analytics and Innovation
Description

AI-powered intelligence platform built to address the distinct challenges of Medical Affairs, enabling analysis, insight discovery, content generation, and engagement optimization.

3Medical Strategy and Excellence
CategoryMedical Affairs Consulting
Description

Consulting service designing and delivering customized approaches to accelerate achievement of Medical Affairs goals, including strategic mindset, analytical skills, therapeutic area knowledge, and best practices for solutions that are meaningful, achievable, and measurable.

4Patient Engagement
CategoryPatient Engagement Services
Description

Patient engagement services including strategic consultancy, patient insights and co-creation of solutions, and patient education and activation. Supports delivery of patient-centric strategy, insights, and education across the drug development lifecycle with focus on health literacy and inclusivity.

5Clinical Trials Optimization
CategoryClinical Trial Optimization
Description

End-to-end clinical trial support from design through recruitment to real-world implementation, specializing in recruitment planning and rescue, quality and risk management, trial diversity, and study start-up with expertise across multiple therapeutic areas.

6Medical Analytics and Innovation
CategoryMedical Analytics and Innovation
Description

Advanced analytics and digital innovation services including AI and Generative AI capabilities, working at intersection of medical strategy, advanced analytics, and technology to uncover insights that speed time to better strategic decisions.

7Value and Evidence
CategoryMarket Access and Evidence
Description

Consulting and technical execution supporting Medical and Access professionals along entire commercialization pathway for drugs, vaccines, devices, diagnostics, and technologies. Includes pricing and market access strategy, value communications, evidence generation, and HEOR/RWE technical expertise.

8Corporate and Investor Communications
CategoryCorporate Communications
Description

Strategic corporate and financial communications team working with life sciences companies at all stages of development, supporting fundraising, partnering, profile raising, reputation management, and crisis communications with focus on media, investor, and corporate stakeholders globally.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Fishawack Health is a private-equity-backed integrated medical communications and consulting group serving biotech and pharma with medical affairs, scientific communications, and patient engagement offerings — directly comparable to MEDiSTRAVA's integrated services model and customer base.

TypeDirect peer
Description

Real Chemistry (formerly W2O Group) is a data-driven healthcare marketing and communications firm serving biotech and pharma clients with a similar mix of strategic communications, analytics, and AI-enabled services, making it a direct comparable in scale and positioning.

TypeDirect peer
Description

EVERSANA is a privately held life sciences commercial services firm providing market access, patient services, HEOR, and medical communications — directly comparable to MEDiSTRAVA's value & evidence, patient engagement, and commercialization support offerings.

TypeDirect peer
Description

Biolumina is a specialty healthcare advertising agency within Omnicom focused on oncology and specialty biotech launches, providing scientific and creative communications for emerging pharma — closely comparable to MEDiSTRAVA's biotech integrated solutions practice.

TypeBroad incumbent
Description

McCann Health is the global healthcare creative and communications network of IPG, serving large pharma with brand communications, medical affairs, and DTC advertising — overlapping with MEDiSTRAVA's communications work but at much larger scale and broader scope.

TypeBroad incumbent
Description

Publicis Health is the healthcare arm of Publicis Groupe, offering advertising, communications, and consulting to pharma clients worldwide — a broader incumbent competitor that overlaps with MEDiSTRAVA's medical communications and corporate communications offerings.

TypeBroad incumbent
Description

Ogilvy Health is WPP's global healthcare communications network, providing medical education, branding, and consulting to pharma clients — a scaled incumbent competitor with overlapping medical affairs and patient engagement capabilities.

TypeBroad incumbent
Description

Havas Health & You is Havas's integrated global health and wellness network offering creative communications, consulting, and media services to pharma — a broad incumbent with capabilities comparable to MEDiSTRAVA's communications and patient engagement practices.

9Avalanche Health (formerly Fishawack + close-knit merger)
TypeDirect peer
Description

Avalanche Health is the combined entity formed from the merger of Fishawack Group, Dudnyk, and other agencies into a single integrated biopharma commercialization and communications platform — directly comparable to MEDiSTRAVA's integrated biotech commercialization offering.

TypeOthers
Description

Initiate is a healthcare-focused public affairs and communications agency serving pharma and biotech on policy, government relations, and corporate communications — adjacent to MEDiSTRAVA's corporate and investor communications practice but with a policy focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medistrava

Healthcare Consulting Servicesmedistrava.com

Medistrava is an Inizio Medical-owned, London-based professional services consultancy providing biotech and pharma companies with integrated medical affairs, clinical trials optimization, patient engagement, value and evidence, and corporate and investor communications services across seven practice areas.

What Medistrava does

Medistrava is an integrated medical solutions partner serving biotech and biopharma companies, operating as a specialty unit within Inizio Medical — itself part of the broader Inizio group comprising more than 11,500 experts across 50 countries. Founded in 2019 and headquartered in London, the company employs 150+ specialists (firmographics report a 251–500 employee range) and delivers services across seven practice areas: medical strategy and excellence, patient engagement, clinical trials optimization, medical analytics and innovation, value and evidence, and corporate and investor communications. The firm serves clients across the drug development lifecycle, from start-up through commercialization, with named customers spanning emerging biotech (Amber Therapeutics, Enara Bio, Quell Therapeutics, Nouscom, Avillion) through to large pharmaceutical companies (Boehringer Ingelheim, AstraZeneca). Disclosed cumulative track record includes IPO mandates on nine markets raising more than $3.5Bn, M&A transactions with total value of approximately $18Bn, partnering transactions exceeding $23Bn, VC financings above $5Bn, and private financings of approximately $2Bn over a 20+ year period.

Medistrava firmographics

Firmographics
Name
Medistrava
Legal name
MEDiSTRAVA
Website
https://medistrava.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Medistrava is an Inizio Medical-owned, London-based professional services consultancy providing biotech and pharma companies with integrated medical affairs, clinical trials optimization, patient engagement, value and evidence, and corporate and investor communications services across seven practice areas.
Ownership category
akta.pro rank

Medistrava industry classification

Industry
Product category
Healthcare Consulting Services
NAICS
Marketing Consulting Services (541613), Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
SECONDARYMPAAAAAJ
Healthcare/Pharma Creative Agencies
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)

Keywords

  • Medical affairs consulting
  • Clinical trial optimization
  • Biotech communications
  • Patient engagement services
  • Pharmaceutical consulting

Where Medistrava is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Medistrava business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Professional Services - Medical Strategy and Excellence: Consulting and strategic services spanning medical affairs transformation, evidence generation strategy, and market access support for biotech and pharma companies.
  2. Clinical Trials Optimization Services: End-to-end clinical trial consulting and advisory services covering recruitment planning, quality and risk management, trial diversity, and study start-up.
  3. Patient Engagement Services: Patient engagement strategic consultancy, insights gathering, and education/activation services across the drug development lifecycle.
  4. Medical Analytics and Innovation: Advanced analytics, digital innovation consulting, and AI-powered solutions for medical affairs and commercial teams.
  5. Corporate and Investor Communications: Strategic corporate and financial communications services including IPOs, secondary financings, M&A transactions, partnering transactions, and VC financings.
  6. Value and Evidence Services: Pricing and market access strategy, value communications, evidence generation, HEOR and RWE technical expertise along the commercialization pathway.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Medistrava product offering

Product offering

Core offering

MEDiSTRAVA is an integrated medical solutions partner that delivers specialized consulting services to biotech and biopharma companies across the drug development lifecycle. Its core offering spans seven practice areas: Medical Strategy and Excellence, Patient Engagement, Clinical Trials Optimization, Medical Analytics and Innovation (including AI and augmented intelligence), Value and Evidence, and Corporate and Investor Communications. Two flagship technology platforms, iON AI and SITE iMPACT, augment these professional services with AI-powered analytics, content generation, and clinical trial recruitment optimization.

Product overview

MEDiSTRAVA is an integrated medical solutions partner offering a unified platform of specialized services for biotech and biopharma companies. The core offering is organized around seven practice areas: Medical strategy and excellence, Patient engagement (encompassing strategic consultancy, insights and co-creation, education and activation, and Inclusion and Impact), Clinical trials optimization (featuring the flagship SITE iMPACT solution with its three integrated sub-components: SITE iNSIGHTS, SITE eNGAGE, and SITE iNSPIRE), Medical analytics and innovation (including dedicated AI and augmented intelligence services), Value and evidence (with HEOR capabilities), and Corporate and investor communications. The company also offers iON AI as an AI-powered intelligence platform. All services are delivered by over 150 specialists and can be combined into bespoke cross-functional teams to provide scalable solutions from startup through commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

  • SITE iMPACT Flagship clinical trial recruitment strategy combining data-driven site intelligence, real-time trial insights, mock trials, and proactive site engagement to help sponsors design recruitable studies and reduce rescue scenarios. Built on three integrated sub-components: SITE iNSIGHTS (analytics and data mapping), SITE eNGAGE (comprehensive site engagement strategy), and SITE iNSPIRE (patient and site-facing marketing and education materials).
  • iON AI AI-powered intelligence platform built to address the distinct challenges of Medical Affairs, enabling analysis, insight discovery, content generation, and engagement optimization.
  • Medical Strategy and Excellence Consulting service designing and delivering customized approaches to accelerate achievement of Medical Affairs goals, including strategic mindset, analytical skills, therapeutic area knowledge, and best practices for solutions that are meaningful, achievable, and measurable.
  • Patient Engagement Patient engagement services including strategic consultancy, patient insights and co-creation of solutions, and patient education and activation. Supports delivery of patient-centric strategy, insights, and education across the drug development lifecycle with focus on health literacy and inclusivity.
  • Clinical Trials Optimization End-to-end clinical trial support from design through recruitment to real-world implementation, specializing in recruitment planning and rescue, quality and risk management, trial diversity, and study start-up with expertise across multiple therapeutic areas.
  • Medical Analytics and Innovation Advanced analytics and digital innovation services including AI and Generative AI capabilities, working at intersection of medical strategy, advanced analytics, and technology to uncover insights that speed time to better strategic decisions.
  • Value and Evidence Consulting and technical execution supporting Medical and Access professionals along entire commercialization pathway for drugs, vaccines, devices, diagnostics, and technologies. Includes pricing and market access strategy, value communications, evidence generation, and HEOR/RWE technical expertise.
  • Corporate and Investor Communications Strategic corporate and financial communications team working with life sciences companies at all stages of development, supporting fundraising, partnering, profile raising, reputation management, and crisis communications with focus on media, investor, and corporate stakeholders globally.

Quantifiable outcome

  • Advisers to over 100 companies over 20+ year period
  • +4 more outcomes

Companies that use Medistrava

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Medistrava technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Medistrava partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Medistrava competitors and assessment

Company assessment

Direct peers

  • Fishawack Health: Fishawack Health is a private-equity-backed integrated medical communications and consulting group serving biotech and pharma with medical affairs, scientific communications, and patient engagement offerings — directly comparable to MEDiSTRAVA's integrated services model and customer base.
  • Real Chemistry: Real Chemistry (formerly W2O Group) is a data-driven healthcare marketing and communications firm serving biotech and pharma clients with a similar mix of strategic communications, analytics, and AI-enabled services, making it a direct comparable in scale and positioning.
  • EVERSANA: EVERSANA is a privately held life sciences commercial services firm providing market access, patient services, HEOR, and medical communications — directly comparable to MEDiSTRAVA's value & evidence, patient engagement, and commercialization support offerings.
  • Biolumina: Biolumina is a specialty healthcare advertising agency within Omnicom focused on oncology and specialty biotech launches, providing scientific and creative communications for emerging pharma — closely comparable to MEDiSTRAVA's biotech integrated solutions practice.
  • Avalanche Health (formerly Fishawack + close-knit merger): Avalanche Health is the combined entity formed from the merger of Fishawack Group, Dudnyk, and other agencies into a single integrated biopharma commercialization and communications platform — directly comparable to MEDiSTRAVA's integrated biotech commercialization offering.

Broad incumbents

  • McCann Health: McCann Health is the global healthcare creative and communications network of IPG, serving large pharma with brand communications, medical affairs, and DTC advertising — overlapping with MEDiSTRAVA's communications work but at much larger scale and broader scope.
  • Publicis Health: Publicis Health is the healthcare arm of Publicis Groupe, offering advertising, communications, and consulting to pharma clients worldwide — a broader incumbent competitor that overlaps with MEDiSTRAVA's medical communications and corporate communications offerings.
  • Ogilvy Health: Ogilvy Health is WPP's global healthcare communications network, providing medical education, branding, and consulting to pharma clients — a scaled incumbent competitor with overlapping medical affairs and patient engagement capabilities.
  • Havas Health & You: Havas Health & You is Havas's integrated global health and wellness network offering creative communications, consulting, and media services to pharma — a broad incumbent with capabilities comparable to MEDiSTRAVA's communications and patient engagement practices.

Others

  • Initiate Government Relations: Initiate is a healthcare-focused public affairs and communications agency serving pharma and biotech on policy, government relations, and corporate communications — adjacent to MEDiSTRAVA's corporate and investor communications practice but with a policy focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Medistrava compliance and trust

Trust signal

Compliance1 record

Medistrava financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medistrava leadership team

Management profile

Number of profiles

Profiles12 records

Medistrava funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medistrava M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medistrava

What does Medistrava do?

MEDiSTRAVA is an integrated medical solutions partner that delivers specialized consulting services to biotech and biopharma companies across the drug development lifecycle. Its core offering spans seven practice areas: Medical Strategy and Excellence, Patient Engagement, Clinical Trials Optimization, Medical Analytics and Innovation (including AI and augmented intelligence), Value and Evidence, and Corporate and Investor Communications. Two flagship technology platforms, iON AI and SITE iMPACT, augment these professional services with AI-powered analytics, content generation, and clinical trial recruitment optimization.

Is Medistrava a public or private company?

Medistrava is a private company. It is classified as corporate owned and is currently operating.

When was Medistrava founded?

Medistrava was founded in 2019. It employs 51 to 100 people.

Where is Medistrava based?

Medistrava is headquartered in London, United Kingdom, in the Europe region.

How does Medistrava make money?

Six revenue lines are on record. Professional Services - Medical Strategy and Excellence is the primary driver. The others are clinical Trials Optimization Services, patient Engagement Services, medical Analytics and Innovation, corporate and Investor Communications and value and Evidence Services.

Who are Medistrava's main competitors?

Direct peers on record are Fishawack Health, Real Chemistry, EVERSANA, Biolumina and Avalanche Health (formerly Fishawack + close-knit merger). Broad incumbents are McCann Health, Publicis Health, Ogilvy Health and Havas Health & You. Initiate Government Relations is listed as an others.

Does Medistrava have an API?

No public API is recorded for Medistrava.

What industry is Medistrava in?

Medistrava's product category is Healthcare Consulting Services. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR, with a secondary code of MPAAAAAJ, Healthcare/Pharma Creative Agencies. Its NAICS code is 541613 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AiThorityHuntsworth’s MEDiSTRAVA Acquires Medical Analytics firm MedEvokeMEDiSTRAVA acquired US-based medical analytics consultancy MedEvoke, which will operate under its umbrella. The combined group will double in size over 12-18 months, with MedEvoke's leadership transitioning to roles within MEDiSTRAVA. The acquisition aims to expand medical analytics and AI-powered intelligence for pharma and biotech clients.PR NewswireHuntsworth's MEDiSTRAVA acquires medical analytics firm MedEvokeHuntsworth's MEDiSTRAVA has acquired US-based medical analytics consultancy MedEvoke, which will operate under the MEDiSTRAVA umbrella. This acquisition aims to scale MEDiSTRAVA's medical analytics and AI capabilities for pharma and biotech clients by integrating MedEvoke's senior leadership team and staff.PR NewswireIntroducing ScienceAffinity™: A Strategic and Creative Consultancy from MEDiSTRAVA Focusing on Science-Driven Brand StorytellingMEDiSTRAVA, part of Huntsworth Health, has officially launched ScienceAffinity™, a global strategic and creative consultancy focused on integrating science into brand storytelling for health and wellness sectors. Led by global president Vineet Thapar, the new entity leverages a network of over 350 scientists and experts to help clients build evidence-based narratives that drive audience trust and behavior change.PR NewswireMEDiSTRAVA launches GenEra ConsultingMEDiSTRAVA, the global medical division of Huntsworth, announced on November 2, 2020 the launch of GenEra Consulting, a new multi-disciplinary gene and cell therapy practice that provides medical affairs, health economics and outcomes research, and market access expertise to biopharmaceutical companies. The practice draws on the regenerative medicine experience of its subsidiary Creativ-Ceutical and has supported more than 40 gene and cell therapies over the past three years, with over 20 senior consultants across Europe, the US, and Japan. The launch reflects the growing number of accelerated regulatory approvals and investigational candidates in the gene and cell therapy field, which the company states requires specialized expertise to navigate regulatory frameworks, pricing, and patient adoption challenges.